Indicated as monotherapy for Grown ups with HR-constructive, HER2-damaging advanced or metastatic breast most cancers with condition development subsequent endocrine therapy and prior chemotherapy in metastatic location 200 mg PO BID A: Abemaciclib commences working on setting up the remedy, but